Chemical Compound Review:
Vargatef methyl (3Z)-3-[[[4-[methyl-[2-(4...
Synonyms:
QCR-43, cc-88, PubChem20543, S1010_Selleck, BIBF1120, ...
- Phase I open-label study of continuous treatment with BIBF 1120, a triple angiokinase inhibitor, and pemetrexed in pretreated non-small cell lung cancer patients. Ellis, P.M., Kaiser, R., Zhao, Y., Stopfer, P., Gyorffy, S., Hanna, N. Clin. Cancer Res. (2010)
- Antitumor activity of BIBF 1120, a triple angiokinase inhibitor, and use of VEGFR2+pTyr+ peripheral blood leukocytes as a pharmacodynamic biomarker in vivo. Kudo, K., Arao, T., Tanaka, K., Nagai, T., Furuta, K., Sakai, K., Kaneda, H., Matsumoto, K., Tamura, D., Aomatsu, K., De Velasco, M.A., Fujita, Y., Saijo, N., Kudo, M., Nishio, K. Clin. Cancer Res. (2011)